August 10, 2017 Organoids are clusters of cultured cells self-organized into miniature replicas of organs. In this image, neural progenitor cells (NPCs) are green. As the brain organoids increase in size, multi-layer structures composed of NPCs develop with intermediate progenitors (not shown) and cortical layer neurons (red). Cell nuclei are depicted in blue. Credit: Cleber A. Trujillo, UC San Diego
An international team of scientists, led by University of California San Diego School of Medicine researchers, has created a human stem cell-based model of a rare, but devastating, inherited neurological autoimmune condition called Aicardi-Goutieres Syndrome (AGS). In doing so, the team was able to identify unusual and surprising underlying genetic mechanisms that drive AGS and test strategies to inhibit the condition using existing drugs.
Two repurposed FDA-approved drugs showed measurable effect, rescuing cells from the effects of AGS. The findings point to the promise of future clinical trials and to the utility of creating novel stem cell-based models of human diseases when no other models are available.
The findings are published in the August 10 online issue of Cell Stem Cell.
"Our approach can now be used to investigate other neurological conditions, like autism and schizophrenia and overlapping autoimmune disorders that dysfunction in similar ways," said Alysson Muotri, PhD, professor in the UC San Diego School of Medicine departments of Pediatrics and Cellular and Molecular Medicine, director of the UC San Diego Stem Cell Program and a member of the Sanford Consortium for Regenerative Medicine.
First described in 1984, AGS typically involves early-onset inflammation affecting the brain, immune system and skin. Its severity depends upon which genes are involvedthere are six typesbut usually results in pronounced physiological and psychological consequences, from microcephaly (an abnormally small head) and spasticity to skin and vision problems and joint stiffness, all appearing in the first year of life. The syndrome is progressive, resulting in death or a persistent vegetative state in early childhood. Currently, there is no cure; the only treatments are symptomatic or palliative.
The clinical features of AGS mimic those of viral infections acquired in utero, before birth, with increased levels of inflammatory markers and other signatures of inflammatory response. However, Muotri said there is no link between AGS and exogenous pathogens. Previous research has shown that AGS patients have mutations in genes critical to nucleic acid metabolism in the regulation of cellular immune response, among them a deficiency in an enzyme called TREX1, which helps prevent abnormal DNA from accumulating in cells.
Deeper probing into the pathogenesis of AGS has been difficult because animal models do not accurately mimic the human version of the disease. So Muotri, with colleagues, used embryonic stem cells and induced pluripotent stem cells (iPSCs) derived from AGS patients to create six cellular models of the condition. In the past, Muotri's lab has developed similar "disease-in-a-dish" neuronal models of autism, anorexia nervosa and Williams Syndrome, among other rare genetic neurological conditions.
From the iPSCs, they also created cerebral organoids or "mini-brains"larger clusters of neurons that organize themselves into a cortical structure, similar to a developing human cerebral cortex.
The researchers found that with TREX1 not functioning normally, all of the cell models displayed excess extra-chromosomal DNA and that a major source of the excess DNA came from LINE1 (L1) retroelements. L1s are repetitive sequences of DNA with the ability to autonomously copy-and-paste themselves within the human genome. In the past, they have been called "jumping genes" and, because their function within cells is largely unknown, "junk DNA."
However the term "junk DNA" is increasingly becoming a misnomer. In work published in 2005, for example, Muotri and colleagues reported that L1s have a high impact on brain cells compared to other tissues, suggesting an important, if so far mysterious, role in brain development.
Since then, he said, researchers around the world have investigated the role of L1s in creating a genetic mosaicism in the brain. "These are ancient, genomic parasites that replicate inside our cells. The majority of the current work is focusing on the impact of this genome mosaicism, but we decided to also look outside of the nucleus. And what we found was a big surprise."
In some of the AGS cell models created by the researchers, toxins from excess DNA built up. Others showed an abnormal immune response, secreting toxins that induced cell death in other cells. The combined effect in organoids was a massive reduction in neuron growth when the opposite should occur. "These models seemed to mirror the development and progression of AGS in a developing fetus," said Muotri. "It was cell death and reduction when neural development should be rising."
The cell death was trigged by the anti-viral response from the L1 molecules outside the nucleus. "We uncovered a novel and fundamental mechanism, where chronic response to L1 elements can negatively impact human neurodevelopment," said Charles Thomas, a former graduate student in the Muotri lab and first author of the study. "This mechanism seems human-specific. We don't see this in the mouse."
The researchers observed that AGS pathogenesis was similar to a retroviral infection and wondered whether existing HIV antiretroviral drugs might be effective in interfering in L1 replication. Two drugs were tested in the cell models: Stavudine and Lamivudine. Both drugs resulted in reduced L1 and cell toxicity. Cell model growth returned in all cell types and in the complex, differentiated colonies of nerve cells that comprise organoids.
The data supported the idea that HIV drugs could benefit AGS patients, Muotri said. A clinical trial led by study co-author Yanick Crow, MRCP, PhD, at Sorbonne Paris Cite University and the University of Manchester, has already started in Europe.
Muotri said the findings were illuminating and encouraging, providing a platform and impetus for further study of the pathology of neuroinflammation and drug discovery. "It's important to note that while this work focused on AGS, nerve cells in schizophrenia show an overabundance of L1 elementsand there is an overlap with other autoimmune disorders.
"This is a great example of how a fundamental basic research could be rapidly translated into clinics. Are there analogous mechanisms at work in these different diseases? Is this modeling strategy relevant for better understanding and treating them? These are questions we will now pursue."
Explore further: Researchers create model of anorexia nervosa using stem cells
More information: Charles A. Thomas et al, Modeling of TREX1-Dependent Autoimmune Disease using Human Stem Cells Highlights L1 Accumulation as a Source of Neuroinflammation, Cell Stem Cell (2017). DOI: 10.1016/j.stem.2017.07.009
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
- New Progress in Stem-Cell-Free Regenerative Medicine - May 26th, 2019
- The Stem Cell Theory of Cancer | Ludwig Center | Stanford ... - May 26th, 2019
- 10 talks on the future of stem cell medicine | TED Blog - March 23rd, 2019
- Ansary Stem Cell Institute | Department of Medicine - March 10th, 2019
- PRP vs. Stem Cell Therapy in Medicine | NSI Stem Cell - March 9th, 2019
- Top Stem Cell Conferences | Stem Cell Research 2019 ... - March 8th, 2019
- Bone Marrow & Stem Cell Transplant | Weill Cornell Medicine - March 7th, 2019
- Stem Cell | Regenerative medicine | 2019 | Conference ... - January 29th, 2019
- Original Medicine Wellness Center - Functional Medicine ... - January 28th, 2019
- Stem Cell Medicine Licenses Exosome Technology for ... - January 11th, 2019
- Stem Cell Medicine | Murdoch Children's Research Institute - November 30th, 2018
- FAQs - Ocean Springs, MS - Gulf Coast Stem Cell ... - November 14th, 2018
- Hematopoietic stem cell - Wikipedia - November 14th, 2018
- Stem Cell Conferences | Regenerative Medicine Conferences ... - November 12th, 2018
- Stem Cell Conferences | Regenerative Medicine Meetings |Gene ... - November 12th, 2018
- Stem Cell Regenerative Medicine Conferences 2018 Zurich ... - November 2nd, 2018
- Biologic Stem Cell Medicine and Therapy | RestorePDX - November 1st, 2018
- Stem Cell Therapy NYC, Regenerative Medicine Injections ... - July 11th, 2018
- Stem Cell Therapy San Antonio TX | Alternative ... - October 12th, 2017
- Human skin cells transformed directly into motor neurons - Washington University School of Medicine in St. Louis - September 8th, 2017
- Cambridge Enterprise and Qkine to drive stem cell and regenerative medicine research - Business Weekly - September 2nd, 2017
- FDA announces actions regarding stem cell treatments - Lexology (registration) - September 1st, 2017
- Six Japanese arrested over medical treatments using blood taken from umbilical cords, which are popular with Chinese ... - South China Morning Post - September 1st, 2017
- In utero stem cell transplants may replace riskier childhood transplants for multiple conditions - Medical Xpress - August 31st, 2017
- Human Stem Cells Fight Parkinson's Disease in Monkeys - Scientific American - August 31st, 2017
- Puppies benefit from stem cell treatment for children with spina bifida - University of California - August 31st, 2017
- Why Doug Baldwin went to England for stem-cell therapy - The News Tribune (blog) - August 29th, 2017
- FDA moves to curb dangerous stem cell clinics - Philly.com - August 29th, 2017
- Stem Cell Treatment Helps Puppies With Spina Bifida - Technology Networks - August 29th, 2017
- US FDA steps up scrutiny of stem cell therapies - Reuters - August 29th, 2017
- ICMR's stem cell research guidelines soon to be released - ETHealthworld.com - August 29th, 2017
- Stem cell treatment for children with spina bifida helps dogs first - Phys.Org - August 25th, 2017
- 'Beating Heart' Patch Offers New Hope for Desperately Ill Patients - NBCNews.com - August 25th, 2017
- Yeargan Uses Patients Own Cells To Heal - Greater Wilmington Business Journal - August 25th, 2017
- State's Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial - UC San Diego Health - August 25th, 2017
- Researcher Seeks to Unravel the Brain's Genetic Tapestry to Tackle Rare Disorder - University of Virginia - August 23rd, 2017
- Mouse Model of Human Immune System Inadequate for Stem Cell Studies - Technology Networks - August 23rd, 2017
- Mouse model of human immune system inadequate for stem cell ... - Medical Xpress - August 22nd, 2017
- Stem Cell Treatments for Lung Diseases Advance - Healthline - Healthline - August 22nd, 2017
- UTMB lung experiment flies into space - Austin American-Statesman - August 22nd, 2017
- These Six Startups From Y Combinator's Demo Day 1 Are Ready to Transform Our World - Futurism - August 22nd, 2017
- Test results after stem cell transplant for multiple myeloma can ... - Medical Xpress - August 10th, 2017
- Are Stem Cell Companies Abusing ClinicalTrials.gov? - PLoS Blogs (blog) - August 10th, 2017
- Okyanos Center for Regenerative Medicine to Hold Stem Cell Symposium in Freeport - Benzinga - August 9th, 2017
- About Us - Stem Cell Medicine :: STEM CELL MEDICINE LTD. - August 4th, 2017
- Engineered Skin Cells Control Type 2 Diabetes in Mice: Study - Sioux City Journal - August 4th, 2017
- Qkine synchronises licensing deal - Global University Venturing - August 4th, 2017
- Honor for pioneering equine stem cell researcher - Horsetalk - August 3rd, 2017
- Speculator makes case for candidates to end years of hurt for stem cell investors - The Pharma Letter (registration) - July 31st, 2017
- Dozens of US clinics sell unproven stem cell therapies for heart failure - Reuters - July 30th, 2017
- The Big Deal About Stem Cell Therapies and Regenerative Medicine - PR Newswire UK (press release) - July 30th, 2017
- Regenexx Announces Successful Merger with Harbor View Medical - OrthoSpineNews - July 12th, 2017
- Stem Cells Guided by Electric Fields May Offer New Therapies for ... - Genetic Engineering & Biotechnology News (press release) - July 12th, 2017
- Danvers health group offers alternative solution to surgery - Wicked Local North of Boston - July 4th, 2017
- LMU-DCOM student selected for research project - The Middlesboro Daily News - July 1st, 2017
- Siberian scientists say stem cells can treat varicose veins - Russia Beyond the Headlines - June 30th, 2017
- Stemcell Stroke hold the key to changing the face of medicine forever. - Checkbiotech.org (press release) - June 30th, 2017
- A New Path for US Stem Cell Inc (OTCMKTS:USRM) - The Oracle Dispatch - June 28th, 2017
- UIC Launches Stem Cell, Regenerative Medicine Center - Chicago Tonight | WTTW - June 13th, 2017
- Stem Cell Research at Johns Hopkins Medicine: Spinal ... - May 29th, 2017
- INTERNATIONAL REGENERATIVE MEDICINE COMMUNITY TO ... - GlobeNewswire (press release) - May 13th, 2017
- Fighting arthritis: Researchers edit stem cells to fight inflammation - Kasmir Monitor - April 29th, 2017
- California's $3-billion bet on stem cells faces final test - Nature.com - April 29th, 2017
- Streamlining Stem Cell Manufacturing - Genetic Engineering & Biotechnology News (press release) - April 24th, 2017
- Cord Blood Association Names STEM CELLS Translational ... - Benzinga - April 1st, 2017
- 3 women blinded in stem cell clinical trial - AOL - March 17th, 2017
- Stem Cell Therapies for Degenerative Disc Disease - Clinical Pain Advisor (registration) - March 17th, 2017
- UC Davis licenses novel compound that helps stem cells regenerate bone - HealthCanal.com (press release) (blog) - March 4th, 2017
- Study of SanBio's Stem Cell Treatment for Stroke Receives Innovation Award from American Heart Association - Yahoo Finance - February 27th, 2017
- World-Renowned Stem Cell Transplantation Expert joins Cellect's Advisory Board - P&T Community - February 27th, 2017
- Obesity reprograms muscle stem cells -- ScienceDaily - Science Daily - February 23rd, 2017
- Early-stage study validates Cellect Bio's method of stem cell selection; shares ahead 19% - Seeking Alpha - February 22nd, 2017
- Cancer stem cell - Wikipedia - February 4th, 2017
- Adult Stem Cell Medicine Technology | Asymmetrex - November 27th, 2016
- Duke Stem Cell and Regenerative Medicine Program - November 2nd, 2015
- Eli and Edythe Broad Center for Regenerative Medicine and ... - October 22nd, 2015
- California Stem Cell Report - October 17th, 2015
- Hair Restoration Treatment Uses Novel Stem Cell Therapy ... - October 12th, 2015
- CD47 - Research and Clinical Trials - Institute for Stem ... - September 25th, 2015
- Stem Cells News -- ScienceDaily - September 8th, 2015